Canaccord raised the firm’s price target on iRhythm (IRTC) to $212 from $193 and keeps a Buy rating on the shares. The firm said they had a stellar quarter, highlighted by strength across both product lines (Monitor and AT), strong FCF, and increased guidance with revenue and adj. EBITDA guidance raised more than the beat.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- Irhythm Technologies: Strong Q3 Performance and Positive Outlook Justify Buy Rating
- Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
- iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
- iRhythm Technologies Reports Strong Q3 2025 Growth
- Closing Bell Movers: Amazon soars to all-time highs on earnings